POLYMED / Q1-FY26 / risks

Keep the risk register visible.

Poly Medicure · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

WatchQ1-FY26 · 2025-07-09Back to quarter ↗

Risk intelligence

Material risks this quarter

European market inventory destocking extended beyond expectations

Chinese companies aggressively dumped products in European market due to US-China tariff situation, causing customer inventory reduction from 4-5 months to 2-3 months. While green shoots visible, full recovery uncertain.

high

US tariff escalation on India exports

50% tariff on India-US trade flagged as unsustainable. While current US revenue <$3.5 million (insulated), uncertainty around US market expansion and CDMO contracts (one US partner) creates execution risk.

medium

Management's earlier guidance accuracy questioned

Analyst Batra pointedly asked about lessons from being 'caught by surprise' as international growth guidance was revised sharply downward within a year. Management acknowledged signs were visible last quarter but recalibration happened only after Q1 impact.

medium

Government business exit accelerating

Government segment declined 10% in Q1 as company exits low-margin business, consistent with strategy but creates near-term revenue headwind until private sector ramp-up compensates.

low